GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Resmed Inc. (RMD) [hlAlert]

Rating:
Neutral RMD
up 11.27 %

Resmed Inc. (RMD) downgraded to Neutral by BofA/Merrill

Posted on: Wednesday,  May 13, 2015  10:25 AM ET by BofA/Merrill

BofA/Merrill rated Neutral Resmed Inc. (NYSE: RMD) on 05/13/2015. Previously BofA/Merrill rated Buy Resmed Inc. (NYSE: RMD) on 08/26/2013., when
the stock price was $49.65. Since then, Resmed Inc. has gained 11.28% as of 05/13/2015's recent price of $55.25.
If you would have followed the previous BofA/Merrill's recommendation on RMD, you would have gained 11.27% of your investment in 625 days.

ResMed Inc. is a holding company. Through its subsidiaries, the Company develops, manufactures and distributes medical equipment for treating, diagnosing and managing sleep-disordered breathing (SDB) and other respiratory disorders, including obstructive sleep apnea (OSA). It has developed nasal continuous positive airway pressure (CPAP) as a non-invasive treatment for OSA. CPAP systems deliver pressurized air, typically through a nasal mask, to prevent collapse of the upper airway during sleep. The Company has developed a number of products for SDB and other respiratory disorders, including airflow generators, diagnostic products, mask systems, headgear and other accessories. ResMed Inc. sells its products in over 70 countries through a combination of wholly owned subsidiaries and independent distributors to sleep clinics, home healthcare dealers and third-party payers. On April 30, 2009, it acquired Respicure Medsys PVT.LTD. In October 2009, ResMed Inc. acquired Laboratoires Narval.

BofA/Merrill
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/13/2015 10:25 AM Hold
None
55.25
as of 8/27/2015
1 Week   
1 Month   
3 Months   
1 YTD up  17.35 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/26/2013 8:25 AM Buy
None
49.65

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy